Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis

Chemico-Biological Interactions

Volumn 183, Issue 1, 2010, Pages 231-237

  Chang, Nai Wen ^a   Pei, Ren Jeng ^b   Tseng, Hsien Chang ^c   Yeh, Kun Tu ^d   Chan, Hsu Chin ^a   Lee, Miau Rong ^a   Lin, Chingju ^e   Hsieh, Wen Tsong ^e   Kao, Ming Ching ^e   Tsai, Ming Hsui ^c   Lin, Chin Fen ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

B crystallin; 4 Nitroquinoline 1 oxide; Arecoline; Hsp27; Oral cancer

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ALPHA CRYSTALLIN; ARECOLINE; BETA CRYSTALLIN; HEAT SHOCK PROTEIN 27;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PAPILLOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE CANCER; TONGUE CARCINOMA; TUMOR GROWTH;

4-NITROQUINOLINE-1-OXIDE; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; ARECOLINE; CARCINOGENS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; SURVIVAL ANALYSIS; TONGUE NEOPLASMS; UP-REGULATION;

ANIMALIA; MURINAE; MUS;

EID: 71249164332     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.10.005     Document Type: Article

References (23)

1. Chiang S.L., Jiang S.S., Wang Y.J., Chiang H.C., Chen P.H., Tu H.P., Ho K.Y., Tsai Y.S., Chang I.S., and Ko Y.C. Characterization of arecoline-induced effects on cytotoxicity in normal human gingival fibroblasts by global gene expression profiling. Toxicol. Sci. 100 (2007) 66-74
2. Jeng J.H., Chang M.C., and Hahn L.J. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 37 (2001) 477-492
3. Chen Y.J., Chang J.T., Liao C.T., Wang H.M., Yen T.C., Chiu C.C., Lu Y.C., Li H.F., and Cheng A.J. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 99 (2008) 1507-1514
4. Nair J., Ohshima H., Friesen M., Croisy A., Bhide S.V., and Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 6 (1985) 295-303
5. Tang X.H., Knudsen B., Bemis D., Tickoo S., and Gudas L.J. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin. Can. Res. 10 (2004) 301-313
6. Kitano M. Host genes controlling the susceptibility and resistance to squamous cell carcinoma of the tongue in a rat model. Pathol. Int. 50 (2000) 353-362
7. Vitale-Cross L., Czerninski R., Amornphimoltham P., Patel V., Molinolo A.A., and Gutkind J.S. Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer. Cancer Prev. Res. (Philadelphia, PA) 2 (2009) 419-422
8. Kondo S. A test for mutation theory of cancer: carcinogenesis by misrepair of DNA damaged by 4-nitroquinoline 1-oxide. Br. J. Cancer 35 (1977) 595-601
9. Winkle S.A., and Tinoco Jr. I. Interactions of 4-nitroquinoline 1-oxide with deoxyribodinucleotides. Biochemistry 18 (1979) 3833-3839
10. Nair U., Bartsch H., and Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19 (2004) 251-262
11. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 85 (2004) 1-334
12. Prokopczyk B., Rivenson A., Bertinato P., Brunnemann K.D., and Hoffmann D. 3-(Methylnitrosamino) propionitrile: occurrence in saliva of betel quid chewers, carcinogenicity and DNA methylation in F344 rats. Cancer Res. 47 (1987) 467-471
13. Stich H.F., and Tsang S.S. Promoting activity of betel quid ingredients and their inhibition by retinol. Cancer Lett. 45 (1989) 71-77
14. Lo W.Y., Tsai M.H., Tsai Y., Hua C.H., Tsai F.J., Huang S.Y., Tsai C.H., and Lai C.C. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta 376 (2007) 101-107
15. Arrigo A.P., Simon S., Gibert B., Kretz-Remy C., Nivon M., Czekalla A., Guillet D., Moulin M., Diaz-Latoud C., and Vicart P. Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 581 (2007) 3665-3674
16. Czerninski R., Amornphimoltham P., Patel V., Molinolo A.A., and Gutkind J.S. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev. Res. (Philadelphia, PA) 2 (2009) 27-36
17. Hasina R., Martin L.E., Kasza K., Jones C.L., Jalil A., and Lingen M.W. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prev. Res. (Philadelphia, PA) 2 (2009) 385-393
18. Trivedy C.R., Craig G., and Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict. Biol. 7 (2002) 115-125
19. Bhide S.V., Gothoskar S.V., and Shivapurkar N.M. Arecoline tumorigenicity in Swiss strain mice on normal and vitamin B deficient diet. J. Cancer Res. Clin. Oncol. 107 (1984) 169-171
20. Tsai Y.S., Lee K.W., Huang J.L., Liu Y.S., Juo S.H., Kuo W.R., Chang J.G., Lin C.S., Jong Y.J., and Arecoline. a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology 249 (2008) 230-237
21. Steidler N.E., and Reade P.C. Experimental induction of oral squamous cell carcinomas in mice with 4-nitroquinolone-1-oxide. Oral Surg. Oral. Med. Oral. Pathol. 57 (1984) 524-531
22. Moyano J.V., Evans J.R., Chen F., Lu M., Werner M.E., Yehiely F., Diaz L.K., Turbin D., Karaca G., Wiley E., Nielsen T.O., Perou C.M., and Cryns V.L. AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J. Clin. Invest. 116 (2006) 261-270
23. Sheu J.J., Hua C.H., Wan L., Lin Y.J., Lai M.T., Tseng H.C., Jinawath N., Tsai M.H., Chang N.W., Lin C.F., Lin C.C., Hsieh L.J., Wang T.L., Shih I.M., and Tsai F.J. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma. Cancer Res. 69 (2009) 2568-2576